Beta Bionics (BBNX) News Today $17.20 +1.84 (+11.98%) As of 05/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period The Goldman Sachs Group Initiates Coverage on Beta Bionics (NASDAQ:BBNX)June 1 at 2:20 AM | americanbankingnews.comBeta Bionics (NASDAQ:BBNX) Coverage Initiated at The Goldman Sachs GroupThe Goldman Sachs Group assumed coverage on Beta Bionics in a research report on Friday. They set a "neutral" rating and a $16.00 price objective for the company.May 31 at 9:28 AM | marketbeat.comWolfe Research Initiates Coverage on Beta Bionics (NASDAQ:BBNX)Wolfe Research assumed coverage on shares of Beta Bionics in a report on Friday. They issued an "outperform" rating and a $20.00 target price for the company.May 31 at 9:28 AM | marketbeat.comBeta Bionics (NASDAQ:BBNX) Coverage Initiated by Analysts at Wolfe ResearchMay 31 at 2:56 AM | americanbankingnews.comWolfe Research Initiates Coverage of Beta Bionics (BBNX) with Outperform RecommendationMay 31 at 2:56 AM | msn.comBeta Bionics (NASDAQ:BBNX) Trading 7.2% Higher - Still a Buy?Beta Bionics (NASDAQ:BBNX) Shares Up 7.2% - Here's WhyMay 30 at 4:16 PM | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 5.7% - Time to Sell?Beta Bionics (NASDAQ:BBNX) Shares Down 5.7% - Time to Sell?May 25, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Consensus Rating of "Moderate Buy" by BrokeragesBeta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine research firms that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating, five have given a buy rating and one hMay 12, 2025 | marketbeat.comLeerink Partnrs Expects Higher Earnings for Beta BionicsBeta Bionics, Inc. (NASDAQ:BBNX - Free Report) - Leerink Partnrs boosted their Q2 2025 earnings estimates for shares of Beta Bionics in a report released on Tuesday, May 6th. Leerink Partnrs analyst M. Kratky now expects that the company will earn ($0.46) per share for the quarter, up from theirMay 11, 2025 | marketbeat.comBeta Bionics, Inc. (BBNX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comBeta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025May 10, 2025 | finanznachrichten.deBeta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025May 6, 2025 | globenewswire.comBeta Bionics to Present at the Bank of America Securities Health Care ConferenceMay 1, 2025 | globenewswire.comBeta Bionics, Inc. (BBNX)April 24, 2025 | finance.yahoo.comBeta Bionics: Slowing Down Or Being Conservative?April 24, 2025 | seekingalpha.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by BrokeragesBeta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) has received an average rating of "Moderate Buy" from the nine brokerages that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation aApril 16, 2025 | marketbeat.comBeta Bionics to Host Investor Event on June 22, 2025April 9, 2025 | globenewswire.comBeta Bionics, Inc. (BBNX) Receives a Buy from Stifel NicolausApril 5, 2025 | markets.businessinsider.comBBNX Beta Bionics, Inc.April 3, 2025 | seekingalpha.comBeta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Here's What HappenedBeta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Here's What HappenedApril 2, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Stock Price Up 2.8% - Here's What HappenedBeta Bionics (NASDAQ:BBNX) Shares Up 2.8% - What's Next?April 1, 2025 | marketbeat.comBeta Bionics welcomes new board member Gerard MichelMarch 29, 2025 | uk.investing.comQ1 EPS Estimates for Beta Bionics Reduced by Leerink PartnrsBeta Bionics, Inc. (NASDAQ:BBNX - Free Report) - Investment analysts at Leerink Partnrs lowered their Q1 2025 EPS estimates for shares of Beta Bionics in a research note issued on Wednesday, March 26th. Leerink Partnrs analyst M. Kratky now forecasts that the company will earn ($0.51) per share fMarch 29, 2025 | marketbeat.comBeta Bionics Announces Board Appointment of Gerard MichelMarch 27, 2025 | globenewswire.comBeta Bionics (NASDAQ:BBNX) Stock Price Down 3% - Here's WhyBeta Bionics (NASDAQ:BBNX) Trading Down 3% - Should You Sell?March 27, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Hits New 52-Week Low After Earnings MissBeta Bionics (NASDAQ:BBNX) Hits New 1-Year Low After Earnings MissMarch 27, 2025 | marketbeat.comBeta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025March 26, 2025 | finanznachrichten.deBeta Bionics reports Q4 EPS ($2.72), consensus ($1.22)March 26, 2025 | markets.businessinsider.comBeta Bionics, Inc. (BBNX) Gets a Buy from Piper SandlerMarch 26, 2025 | markets.businessinsider.comBeta Bionics (NASDAQ:BBNX) Announces Earnings ResultsBeta Bionics (NASDAQ:BBNX - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($1.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($1.40).March 26, 2025 | marketbeat.comBeta Bionics stock surges as Q4 revenue more than doublesMarch 26, 2025 | in.investing.comBeta Bionics (NASDAQ:BBNX) Trading Down 3% - What's Next?Beta Bionics (NASDAQ:BBNX) Shares Down 3% - Here's What HappenedMarch 25, 2025 | marketbeat.comBeta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025March 25, 2025 | globenewswire.comBeta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of "Moderate Buy" from AnalystsBeta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) has received an average rating of "Moderate Buy" from the nine brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one hasMarch 22, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)March 17, 2025 | markets.businessinsider.comBeta Bionics (NASDAQ:BBNX) Shares Up 7.1% - Here's WhyBeta Bionics (NASDAQ:BBNX) Shares Up 7.1% - Here's What HappenedMarch 15, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Reaches New 52-Week Low - Time to Sell?Beta Bionics (NASDAQ:BBNX) Hits New 1-Year Low - Here's What HappenedMarch 11, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Shares Down 6.6% - Here's WhyBeta Bionics (NASDAQ:BBNX) Shares Down 6.6% - What's Next?March 6, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Hits New 52-Week Low - Should You Sell?Beta Bionics (NASDAQ:BBNX) Reaches New 52-Week Low - Should You Sell?March 5, 2025 | marketbeat.comBeta Bionics, Inc.'s Quiet Period Will Expire on March 11th (NASDAQ:BBNX)Beta Bionics' (NASDAQ:BBNX - Get Free Report) quiet period will expire on Tuesday, March 11th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. During Beta Bionics' quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.March 4, 2025 | marketbeat.comBeta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending RecentlyMarch 3, 2025 | insidermonkey.comBeta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025February 27, 2025 | globenewswire.comBeta Bionics (NASDAQ:BBNX) Hits New 52-Week Low - Here's WhyBeta Bionics (NASDAQ:BBNX) Sets New 12-Month Low - Time to Sell?February 26, 2025 | marketbeat.comLeerink Partnrs Weighs in on Beta Bionics FY2024 EarningsBeta Bionics, Inc. (NASDAQ:BBNX - Free Report) - Investment analysts at Leerink Partnrs issued their FY2024 earnings per share estimates for shares of Beta Bionics in a research report issued on Monday, February 24th. Leerink Partnrs analyst M. Kratky forecasts that the company will post earningsFebruary 26, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Upgraded to Strong-Buy at Leerink PartnrsLeerink Partnrs upgraded Beta Bionics to a "strong-buy" rating in a research report on Monday.February 25, 2025 | marketbeat.comBeta Bionics initiated with an Outperform at LeerinkFebruary 24, 2025 | markets.businessinsider.comBeta Bionics initiated with a Buy at BofAFebruary 24, 2025 | markets.businessinsider.comBeta Bionics (NASDAQ:BBNX) Earns Buy Rating from Analysts at Bank of AmericaBank of America initiated coverage on shares of Beta Bionics in a research note on Monday. They issued a "buy" rating on the stock.February 24, 2025 | marketbeat.comBeta Bionics (NASDAQ:BBNX) Coverage Initiated at Lake Street CapitalLake Street Capital began coverage on Beta Bionics in a report on Monday. They issued a "buy" rating and a $30.00 price objective on the stock.February 24, 2025 | marketbeat.comBeta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Hold" by AnalystsShares of Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) have been assigned an average recommendation of "Hold" from the three brokerages that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating. The average 12 month priceFebruary 24, 2025 | marketbeat.com Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address BBNX Media Mentions By Week BBNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBNX News Sentiment▼0.650.88▲Average Medical News Sentiment BBNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBNX Articles This Week▼103▲BBNX Articles Average Week Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LivaNova News Today Warby Parker News Today NovoCure News Today LeMaitre Vascular News Today Enovis News Today CONMED News Today National Vision News Today Tandem Diabetes Care News Today Cadre News Today Liquidia News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBNX) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBNX Stock Free BBNX Stock Alerts